Obsessive-compulsive Disorder (OCD) Clinical Trial
Official title:
Influence of Pregnenolone on Distress and Autonomic Parameters During Cognitive-behavioral Exposure Therapy in Patients With Obsessive-compulsive Disorder
Characterization of the influence of pregnenolone vs. placebo on subjective distress and autonomic functioning during cognitive-behavioral exposure therapy in patients with obsessive-compulsive disorder.
Main out-come parameters:
Inter-session habituation as per SUD (100 mm VAS), Y-BOCS
Secondary out-come parameter:
HF/LF of HRV, Salivary epinephrine
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02267629 -
Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder
|
Phase 2 | |
Recruiting |
NCT04042038 -
Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder
|
N/A | |
Completed |
NCT02867449 -
Metacognitive Therapy for Obsessive-Compulsive Disorder
|
N/A | |
Completed |
NCT01368510 -
Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder
|
N/A | |
Not yet recruiting |
NCT05422469 -
OCD Biomarker Survey Employing sEEG and Stimulation: The OBSESS Trial
|
N/A | |
Active, not recruiting |
NCT03300947 -
Psilocybin for Treatment of Obsessive Compulsive Disorder
|
Phase 1 | |
Recruiting |
NCT02773082 -
Reclaimâ„¢ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Not yet recruiting |
NCT06360991 -
DBS for Treatment-resistant Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT03605316 -
Deep Electrical Neuromodulation in Obsessive-compulsive Disorder
|